[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100613643":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":24,"locations":30,"responsibleParty":52,"collaborators":55,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":18,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":67,"maxAge":18,"enrollmentInfo":68,"targetDuration":18,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":78,"overallStatus":32,"whyStopped":18,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Medical University of South Carolina","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"SUPPORT-T Intervention Arm","EXPERIMENTAL","Participants in the intervention arm will have a telehealth preparatory visit scheduled 1 week later (Week 2) with the Study Coordinator and will be provided with the study number to call with questions.\n\nSUPPORT-T will be delivered biweekly at TeleHealth Visits 1-4 via a secure interface via MUSC telehealth platform. The nurse interventionist will receive results from the REDCap survey after each TH visit and contact the patient biweekly after each TH visit using the MUSC Telehealth and\u002For Health platform. The nurse interventionist will be available for any questions and communicate with the participants via bi-directional texts (SC will maintain a log of those texts).\n\n• All participants will complete questionnaires at Week 1, Week 9, Month 6, and Month 12",[13],"Other: SUPPORT-T Educational Intervention",{"label":15,"type":16,"description":17,"interventionNames":18},"Enhanced Usual Care Control Group","NO_INTERVENTION","* Participants in the enhanced usual care arm will receive printed education materials from the Pulmonary Fibrosis Foundation (PFF) and the nurse interventionist's contact information.\n* All participants will complete questionnaires at Week 1, Week 9, Month 6, and Month 12",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"SUPPORT-T Educational Intervention","SUPPORT-T will be delivered biweekly at TeleHealth Visits 1-4 via a secure interface via MUSC telehealth platform. The nurse interventionist will receive results from the REDCap survey after each TH visit and contact the patient biweekly after each TH visit using the MUSC Telehealth and\u002For Health platform. The nurse interventionist will be available for any questions and communicate with the participants via bi-directional texts (SC will maintain a log of those texts)",[9],[25],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Kathleen Lindell, PhD, RN, ATSF, FAAN","CONTACT","(843) 792-9763","lindellk@musc.edu",[31],{"facility":5,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Charleston","South Carolina","29425","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-79.93275,32.77632,{"lat":42,"lon":41},[45,49,50],{"name":46,"role":27,"phone":47,"phoneExt":18,"email":48},"Mary Chris Pittman, BA","8432594689","pittmama@musc.edu",{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},{"name":26,"role":51,"phone":18,"phoneExt":18,"email":18},"PRINCIPAL_INVESTIGATOR",{"type":51,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Kathleen Lindell","Associate Professor-Faculty",[56],{"name":57,"class":58},"National Institutes of Health (NIH)","NIH","100613643","support-t-in-patients-with-progressive-pulmonary-fibrosis-and-their-caregivers-100613643",false,"NCT07269262","SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers","Feasibility and Acceptability of a Mobile Application \"SUPPORT-T\" to Increase Equitable Access to Palliative Care in Patients With Progressive Pulmonary Fibrosis (PPF) and Their Caregivers","Inclusion Criteria:\n\n* Adults ≥18 years\n* Confirmed diagnosis of PPF\n* English or Spanish speaking\n\nCaregiver Inclusion Criteria:\n\n* adult, ≥ 18 years old\n* Designated and identified by patient as providing most of the emotional, financial, and\u002For physical support (i.e., the individual most involved in care, does not have to live with patient)\n* Able to speak and understand English.\n\nExclusion Criteria:\n\n\\-","ALL","18 Years",{"count":69,"type":70},170,"ESTIMATED","INTERVENTIONAL",[73],"NA","This pilot randomized controlled trial evaluates the feasibility, acceptability, and accessibility of SUPPORT-T, a digitally delivered palliative care intervention for patients with Progressive Pulmonary Fibrosis (PPF) and their caregivers. The intervention includes a 9-week digital application guided by a nurse interventionist and quarterly virtual support groups over one year. Participants will be recruited from rural South Carolina and urban New York City. The study compares SUPPORT-T to Enhanced Usual Care and aims to inform a future multi-site trial.",[76,77],"Progressive Pulmonary Fibrosis","Interstitial Lung Disease",[79,80],"Education","Interstitial Lung Disease (ILD)","2026-01-29",{"date":83,"type":84},"2026-02-02","ACTUAL",{"date":86,"type":84},"2026-01-13",{"date":88,"type":70},"2027-10-01",{"name":5,"class":6},1]